TU Dresden

CMCB introduces its directorate: Prof. Nils Kröger (B CUBE), Prof. Jochen Guck (BIOTEC) and Prof. Ezio Bonifacio (CRTD)
The Center for Molecular and Cellular Bioengineering (CMCB) introduces its managing director and deputy directors. Prof. Nils Kröger (B CUBE) will lead the CMCB as managing director, Prof. Jochen... [read more]
TU Dresden Summer University at the CRTD
On July 18, 2017 – the CRTD together with the PLID welcomed 25 curious students within the Summer University of TU Dresden. [read more]
Science meets Art at CRTD
On Friday, June 23rd, scientists and artists came together for a joint science art event at the CRTD. The event also celebrated the launch of the third issue of the magazine PLASMA, which includes an... [read more]
© Nils Stelte
Panel discussion on Dresdens Science Night: Research discoveries and experiments
Dresden. On 08.06.2017, a press conference for this year's Dresdens Science Night will take place at 1pm at the Gläserne Manufaktur Dresden. The director of the CRTD, Prof. Dr. Ezio Bonifacio, will... [read more]

At the DFG-Center for Regenerative Therapies Dresden (CRTD), our mission is to understand the biology of stem cells and physiological and pathological tissue and organ repair in order to develop new treatments for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, haematological diseases, such as leukemia, metabolic diseases, such as diabetes, and bone diseases. Our scientists are encouraged to think outside the box and to explore untapped areas of knowledge in the regenerative potential of the human body, and to apply this knowledge to prevent or reverse disease processes.

To achieve our aims, we strongly support interdisciplinary research, with eighteen core groups in a network of 87 principal investigators from diverse research institutes on the Dresden campus, with expertise in everything from the biology of cells and tissues to biomaterials to nanoengineering. CRTD has become a major driving force on campus and is ready to meet the challenges of moving new interventional strategies from bench to bedside.